Mylan stock


Biotech Universe: Mizuho Expects Mylan N.V. (MYL) To Rally, Endocyte, Inc. (ECYT) Brings Wedbush Over To The Bulls

Analysts weigh in with confidence on two biotech stocks blasting through the roof this week.

Wall Street’s Take on Two Biotech Rockets: Mylan N.V. (MYL) and CytomX Therapeutics Inc (CTMX)

Cantor cautiously welcomes MYL’s FDA success as EPS upside; Cowen applauds CTMX’s Probody technology.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts